BeautyMatter NEXT50 2025 brand Sweet Chemistry closed new funding and is still in fundraising mode looking to secure another $1.5 million to $3 million.WHO: Every few decades, a significant advancement moves the skincare industry forward. Launched in 2023 by chemist and innovator Alec Batis and bioengineer Dr. John O’Neill, PhD, Sweet Chemistry was built on decades of life-changing biomedical research and uncompromising cosmetic science. Sweet Chemistry is evidence-based bioactive skincare that repairs and regenerates the skin by utilizing the latest innovation in tissue engineering and organ repair known as Matrikynes—a patent-pending polypeptide concentrate extracted from a natural extracellular matrix of upcycled zero-waste bovine bone.Sweet Chemistry has four products on the market priced from $148 to $170: Barrier Repair Hydra-Serum, Barrier Repair Oil-Serum, Elasticity Reinforcing Hydra-Cream, and Elasticity Reinforcing Lipid-Cream.WHY: The funding will be used for marketing, advertising, product development, and talent.IN THEIR OWN WORDS: Alec Batis, Sweet Chemistry CEO and co-founder, said, “The only reason I decided to risk my life savings on Sweet Chemistry was because I knew the Matrikynes ECM-derived matrikine peptide innovation was a quantum leap beyond what our industry has offered for the past 25 years, and defensible by 8 years of NIH funded research to the tune of $8M and ongoing. Not even my novel activity-optimized emulsions were enough for me to become a skincare founder because I spent years in the lab getting around other’s patents.